Medicine and Dentistry
Naltrexone
70%
Opioid Abuse
66%
Human Immunodeficiency Virus
38%
Abstinence
37%
Placebo
31%
Outpatient
31%
Buprenorphine Plus Naloxone
30%
Clinical Trial
24%
Cannabis Use
22%
Diseases
21%
High Risk Behavior
21%
Buprenorphine
18%
Substance Abuse
17%
Drug Therapy
17%
Alcoholic Polyneuropathy
14%
Cannabis Addiction
12%
Attention Deficit Disorder
12%
Randomized Clinical Trial
11%
Detoxication
11%
Arm
11%
Substance Use Disorder
10%
Cannabis
10%
Smoking
10%
Unprotected Sex
10%
Randomized Controlled Trial
10%
Combination Therapy
9%
Logistic Regression Analysis
9%
Dronabinol
9%
Methadone Treatment
9%
Cocaine Dependence
8%
Adolescence
8%
Drug Dependence Treatment
8%
Analeptic
8%
Patient Characteristics
8%
Human Immunodeficiency Virus Risk Behavior
8%
Repetitive Transcranial Magnetic Stimulation
8%
Infusion
8%
Ketamine
8%
Transcranial Magnetic Stimulation
8%
Sex Difference
7%
Depressive Disorder
7%
Intention-to-Treat Analysis
6%
Maintenance Therapy
6%
Substance Abuse Treatment
6%
Adverse Event
6%
Treatment Group
6%
Behavior Therapy
5%
Self-Administration
5%
Behavioral Treatment
5%
Midazolam
5%
Neuroscience
Naltrexone
65%
Opioid Abuse
61%
Cannabis
52%
Buprenorphine
45%
Placebo
42%
Randomized Controlled Trial
31%
Naloxone
29%
Substance Abuse
28%
Amphetamine
20%
Transcranial Magnetic Stimulation
20%
Attention Deficit Hyperactivity Disorder
20%
Methadone
17%
Cocaine Dependence
16%
Cannabis Addiction
16%
Drug Therapy
15%
Risk Behavior
14%
Human Immunodeficiency Virus
14%
Drug Abuse
10%
Quetiapine
9%
Cognitive Behavioral Therapy
8%
Interleukin 6
8%
Cortisol
8%
Hypochondriasis
8%
Venlafaxine
8%
Ketamine
8%
Antidepressant
6%
Depressive Disorder
6%
Agonist
6%
Major Depressive Disorder
6%
Behavioral Treatment
5%
Fluoxetine
5%
Behavioral Therapy
5%
Midazolam
5%
Analeptic
5%
Pharmacology, Toxicology and Pharmaceutical Science
Diseases
100%
Naltrexone
60%
Placebo
44%
Cannabis
41%
Randomized Controlled Trial
29%
Buprenorphine Plus Naloxone
26%
Clinical Trial
25%
Buprenorphine
21%
Cocaine Dependence
20%
Amphetamine
20%
Pharmacotherapy
17%
Cannabis Addiction
16%
Attention Deficit Disorder
16%
Detoxication
14%
Methadone
13%
Dronabinol
13%
Adverse Event
9%
Ethanol
9%
Combination Therapy
9%
Prevalence
9%
Drug Dependence
8%
Lofexidine
8%
HIV
8%
Randomized Clinical Trial
8%
Ketamine
8%
Hypochondriasis
8%
Topiramate
8%
Lorcaserin
8%
Depressive Disorder
7%
Toxicology
6%
Treatment Group
6%
Withdrawal Syndrome
6%
Midazolam
5%
Intervention Trial
5%
